HMGCS2, LysoPC, and Pulmonary Fibrosis

2026-09-11

Yang et al. identify injured type II alveolar epithelial cells as a major source of accumulated lysophosphatidylcholine in experimental pulmonary fibrosis and show that these lipids activate lung fibroblasts. Their work links epithelial HMGCS2 loss to impaired lipid degradation through PPARα-dependent regulation of CPT1A and CPT2, providing a mechanistic framework for lipid signaling pathway analysis in fibrotic lung disease.

Promethazine HCl: Macrophage Assay Workflows

2026-09-11

Promethazine HCl enables a practical bridge between H1-receptor pharmacology and macrophage host-defense assays. This workflow emphasizes ROS, lysosomal activity, autophagy, controls, and troubleshooting so researchers can distinguish pathway modulation from nonspecific cytotoxicity.

Autophagy Modulates Resveratrol-Induced Apoptosis in RCC

2026-09-10

Yao and colleagues showed that resveratrol induces mitochondrial, ROS-associated apoptosis in renal cell carcinoma 786-O cells while simultaneously activating a protective JNK-dependent autophagy response. The study’s central implication is that autophagy inhibition may increase resveratrol-associated tumor-cell killing, although the finding remains limited to an in vitro model and requires broader validation.

Caspase-3 Fluorometric Assay Kit: Mechanistic Readout

2026-09-10

The Caspase-3 Fluorometric Assay Kit converts DEVD cleavage into a quantitative apoptosis readout. This article explains how to interpret caspase-3 activity measurement in treatment-induced cell death, using hyperthermia–cisplatin research to distinguish pathway activation from phenotype attribution.

5-HT3 Antagonists and Renal OCT2/MATE1 Transport

2026-09-09

The reference study systematically compared five 5-HT3 antagonist drugs as inhibitors of the renal organic cation transporters OCT2 and MATE1, using complementary cellular models. Its findings show that transporter inhibition is compound- and transporter-specific, providing a mechanistic basis for evaluating drug–drug interactions involving renal secretion of cationic compounds.

Tropisetron Hydrochloride Assay Workflows

2026-09-09

Tropisetron Hydrochloride supports paired receptor and renal transporter experiments, helping researchers separate 5-HT3 signaling from OCT2/MATE1-mediated effects. This workflow emphasizes concentration design, model selection, stability, and troubleshooting for reproducible neuroscience receptor modulation and serotonin receptor signaling research.

Ajugol, Mitophagy, and Pyroptosis in Gouty Arthritis

2026-09-08

The reference study identifies impaired PINK1/Parkin-dependent mitophagy as a mechanistic link between mitochondrial stress and chondrocyte pyroptosis in acute gouty arthritis. By combining computational analyses with cell and mouse experiments, it shows that ajugol suppresses the PI3K/AKT/mTOR axis, restores mitochondrial quality control, and reduces inflammatory cartilage injury.

Pitavastatin (NK-104) In Vitro Workflow Guide

2026-09-08

Pitavastatin (NK-104, SKU B1124) provides a defined HMG-CoA reductase inhibitor for cell-based and biochemical studies of cholesterol biosynthesis. It is suitable for exploratory cardiovascular and atherosclerosis research, including mitophagy-related assays, but should not be used as a clinical, therapeutic, or unvalidated animal-dosing protocol.

Merbromin as a Selective SARS-CoV-2 3CLpro Inhibitor

2026-09-07

WIP1, p38 MAPK, and Pyroptosis in Septic AKI

2026-09-07

This study identifies WIP1/PPM1D as an inducible brake on p38 MAPK-associated renal tubular pyroptosis during sepsis-associated acute kidney injury. By combining single-cell data, patient and mouse tissue analysis, HK2-cell experiments, and pharmacological inhibition, it links WIP1 activity to preservation of tubular cell viability while highlighting important limits of the current evidence.

FGFR2::SHTN1 Fusion and Shootin1 Oncogenicity

2026-09-05

The reference study provides the first molecular characterization of the FGFR2::SHTN1 fusion, showing how Shootin1 coiled-coil domains may convert an intact FGFR2 kinase into a ligand-independent signaling unit. Its combination of fusion mapping, structural modeling, oligomerization analysis, and biochemical validation offers a mechanistic framework for interpreting this alteration in cholangiocarcinoma and related cancers.

Tricine-SDS-PAGE Gel Preparation Kit Guide

2026-09-04

The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is designed to improve resolution of low-molecular-weight proteins and peptides that are difficult to distinguish with conventional Tris-glycine SDS-PAGE. It is intended for scientific research workflows, including denaturing electrophoresis and non-denaturing electrophoresis, and is not intended for diagnostic or medical use.

AmpliFold Capture-and-Release in Lateral Flow Assays

2026-09-04

The AmpliFold strategy addresses a central sensitivity bottleneck in lateral flow assays by temporarily capturing analyte-bound complexes, triggering their release, and enabling high-affinity rebinding before signal development. In a HER2 model, the reference study reports up to 16-fold improvement in the limit of detection and a 12-fold sensitivity enhancement with large gold nanoparticles, while also identifying linker design, receptor density, and capture geometry as critical variables.

Cinoxacin Workflows for Gram-Negative UTI Research

2026-09-03

Cinoxacin provides a historically defined quinolone antibiotic comparator for susceptibility testing, time-kill experiments, and resistance selection in urinary Gram-negative isolates. Its narrow activity profile and practical assay benchmarks make it especially useful for controlled urinary tract infection research rather than broad-spectrum screening.

Acridine Orange hydrochloride: Practical Staining Guide

2026-09-03

Acridine Orange hydrochloride provides cell-permeable, differential fluorescence for nucleic acid staining, supporting cell cycle analysis, apoptosis detection, and flow-based DNA/RNA assessment. This guide explains preparation, controls, readout planning, and limitations; it should not be treated as a universal substitute for orthogonal apoptosis or nucleic acid assays.